Bone Marrow TransplantationHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsGraft SurvivalStem CellsWhole-Body IrradiationTransplantation ChimeraHematopoietic Stem Cell MobilizationHematopoietic Stem CellsCord Blood Stem Cell TransplantationBusulfanTissue DonorsCombined Modality TherapyLiver TransplantationCyclophosphamideTreatment OutcomeGranulocyte Colony-Stimulating FactorMelphalanLeukemiaHistocompatibility TestingRecurrenceAntigens, CD34HistocompatibilityAnemia, AplasticLeukapheresisRemission InductionMultiple MyelomaTransplantation, IsogeneicAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsHematopoiesisKidney TransplantationMyeloablative AgonistsLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteTime FactorsBone and BonesRetrospective StudiesBone Marrow PurgingBlood Component RemovalSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDisease-Free SurvivalBone Marrow DiseasesGraft vs Leukemia EffectEtoposideSurvival RateHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesInfectionTransplantation ImmunologyLymphocyte DepletionHLA AntigensImmunosuppressionT-LymphocytesHepatic Veno-Occlusive DiseaseMesenchymal Stem Cell TransplantationBlood CellsAntineoplastic Agents, AlkylatingCell TransplantationGraft RejectionCytarabineHeart TransplantationSalvage TherapyHodgkin DiseaseAcute DiseaseFollow-Up StudiesCarmustineVidarabineCytomegalovirus InfectionsThiotepaCell DifferentiationMice, Inbred C57BLCyclosporineLymphomaLung TransplantationFatal OutcomeLymphocyte TransfusionGraft vs Tumor EffectFlow CytometryLeukocyte CountLeukemia, MyeloidVincristineNuclear FamilyColony-Forming Units AssayCells, CulturedLeukocyte TransfusionImmunophenotypingOrgan TransplantationPlatelet CountPrognosis